Your browser is no longer supported. Please, upgrade your browser.
JNJ Johnson & Johnson daily Stock Chart
Johnson & Johnson
IndexDJIA S&P500 P/E24.53 EPS (ttm)5.33 Insider Own0.07% Shs Outstand2.68B Perf Week0.72%
Market Cap350.40B Forward P/E15.18 EPS next Y8.61 Insider Trans-22.33% Shs Float2.68B Perf Month0.21%
Income14.54B PEG3.16 EPS next Q1.95 Inst Own68.70% Short Float0.59% Perf Quarter-6.29%
Sales81.38B P/S4.31 EPS this Y-12.20% Inst Trans0.11% Short Ratio1.59 Perf Half Y3.77%
Book/sh24.09 P/B5.43 EPS next Y5.46% ROA1.00% Target Price146.39 Perf Year-11.05%
Cash/sh7.22 P/C18.10 EPS next 5Y7.76% ROE2.50% 52W Range118.62 - 148.99 Perf YTD1.27%
Dividend3.60 P/FCF38.37 EPS past 5Y6.20% ROI15.10% 52W High-12.28% Beta0.69
Dividend %2.75% Quick Ratio1.40 Sales past 5Y2.60% Gross Margin66.50% 52W Low10.17% ATR3.07
Employees134000 Current Ratio1.70 Sales Q/Q3.60% Oper. Margin21.40% RSI (14)47.86 Volatility1.33% 2.14%
OptionableYes Debt/Eq0.48 EPS Q/Q4.90% Profit Margin1.90% Rel Volume1.07 Prev Close129.09
ShortableYes LT Debt/Eq0.46 EarningsJan 22 BMO Payout526.10% Avg Volume9.88M Price130.69
Recom- SMA202.15% SMA50-4.87% SMA200-1.12% Volume10,592,835 Change1.24%
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Oct-09-17Upgrade Wells Fargo Market Perform → Outperform
Sep-25-17Initiated Citigroup Neutral $140
Sep-20-17Downgrade Goldman Neutral → Sell $125 → $130
Jul-21-17Downgrade BTIG Research Neutral → Sell $110
Jul-21-17Downgrade Alembic Global Advisors Neutral → Underweight
Jul-20-17Resumed Credit Suisse Outperform $148
Jul-05-17Reiterated Morgan Stanley Overweight $135 → $140
May-18-17Reiterated Stifel Hold $124 → $128
Jan-20-19 11:30AM  Better Buy: AbbVie vs. Johnson & Johnson Motley Fool
10:49AM  16 Stocks Jim Cramer Says Could Win from a U.S.-Chinese Trade Deal
Jan-19-19 01:00PM  3 Stocks You Don't Realize You Use Every Day Motley Fool
Jan-18-19 10:50PM  JOHNSON & JOHNSON INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Johnson & Johnson - JNJ PR Newswire
07:01PM  New Rules for This Market: Cramer's 'Mad Money' Recap (Friday 1/18/19)
06:27PM  Cramer's game plan: This week, forecasts are more importa... CNBC Videos
06:10PM  Cramer's game plan: This week, forecasts are more important than earnings CNBC
05:45PM  AbbVie's Imbruvica fails to meet main goal in pancreatic cancer study Reuters
05:10PM  What Happened in the Stock Market Today Motley Fool
04:10PM  Key Takeaways from Q4 Earnings Results Thus Far Zacks
03:16PM  Apple Expands in Healthcare, Partners Johnson & Johnson Zacks
02:59PM  Should You Load Up on JNJ Stock Before Earnings? InvestorPlace
01:42PM  Apple Watch and Johnson & Johnson Team Up for Heart Study Motley Fool
12:30PM  3 Earnings Reports to Watch Next Week InvestorPlace
10:11AM  Johnson & Johnson to wield Apple Watch for health-tech study American City Business Journals
08:10AM  Johnson & Johnson Is Trying to Recover From Plunge Investopedia
07:49AM  The Daily Biotech Pulse: Regulatory Roadblock For Immunomedics, AdCom Split On Lexicon's Diabetes Drug Benzinga
Jan-17-19 09:35PM  Apple, Johnson & Johnson Team Up for Healthcare Project Involving Apple Watch
07:44PM  [$$] Johnson & Johnson to Use Apple Watch App for Heart-Health Study The Wall Street Journal
07:28PM  [$$] Johnson & Johnson to Use Apple Watch App for Heart-Health Study The Wall Street Journal
05:20PM  MediPharm Labs, Pure Global Cannabis, Weekend Unlimited, Plus Products, Trulieve Make Elevator Pitches Benzinga
09:15AM  Banks Keep Stocks Moving Higher Zacks
09:06AM  J&J (JNJ) to Commence Pharma Q4 Earnings: What to Expect Zacks
08:43AM  Apple and Johnson & Johnson collaborating on heart research project MarketWatch
08:30AM  Johnson & Johnson Announces Research Study with Apple Watch to Help Improve AFib Outcomes Including Stroke Prevention PR Newswire
08:17AM  3 Weight-Loss Stocks in Focus on Rising Obesity Fears Zacks
08:06AM  The Daily Biotech Pulse: FDA Panel Backs Amgen's Hypertension Drug, Adamis Allergy Drug Launched In US Benzinga
07:00AM  Johnson & Johnson Completes Acquisition of Ci:z Holdings Co., Ltd. PR Newswire
Jan-15-19 05:45PM  Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know Zacks
11:42AM  Cannabis Company Avicanna Eyes Canadian IPO Benzinga
10:30AM  Johnson & Johnson (JNJ) Earnings Expected to Grow: Should You Buy? Zacks
09:00AM  Why Geron Stock Dropped 44% in 2018 Motley Fool
08:11AM  Health Care Stocks Face Political Risk, How I'm Playing Netflix: Market Recon
Jan-14-19 06:00PM  Is Teva Pharmaceutical Industries Limited Stock a Bargain? Motley Fool
04:08PM  U.S. lawmaker launches investigation into pharma drug pricing Reuters
12:42PM  House Dems announce sweeping investigation of drug pricing Associated Press
12:09PM  House Democrats launch drug-pricing probe into a dozen major health-care companies CNBC
10:59AM  A Look at Dow ETF Ahead of Q4 Earnings Zacks
Jan-13-19 12:00PM  Stock Market Power Rankings: Amazon Back on Top Motley Fool
Jan-12-19 03:08PM  ATTENTION JNJ EMPLOYEES: Zamansky LLC Investigates Possible ERISA Violations in the Johnson & Johnson Savings Plan Business Wire
09:07AM  Here's Why Arrowhead Pharmaceuticals Shot 237.5% Higher in 2018 Motley Fool
Jan-11-19 05:00PM  Johnson & Johnson Recommends Rejection Of Below-Market "Mini-Tender" Offer By Peer & Peri LLC PR Newswire
04:14PM  Why This Group Is 'An Attractive Destination For Investors' In 2019 Investor's Business Daily
04:14PM  Why This IBD Stock Of The Day Broke Out Despite Biotech Turbulence Investor's Business Daily
02:27PM  J&J raises prices on around two dozen drugs Yahoo Finance Video
10:29AM  WW downgraded, Googles board faces lawsuits, J&J hikes some prices Yahoo Finance Video
07:00AM  Johnson & Johnson Announces completion of Offer for Ci:z Holdings Co., Ltd. PR Newswire
06:22AM  4 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2019 Zacks
03:14AM  Stocks - Apple, Starbucks Fall in Premarket, Activision Tumbles, Netflix Gains
Jan-10-19 07:19PM  Surgeons fear pelvic mesh lawsuits will spook patients Associated Press
06:31PM  Johnson & Johnson raises U.S. prices on around two dozen drugs Reuters
06:27PM  J&J raises U.S. prices on around two dozen drugs Reuters
01:54PM  20 Women Set To Dominate The International Cannabis Space In 2019 Benzinga
10:24AM  Dr. Paul Janssen Award for Biomedical Research Issues 2019 Call for Nominations to Celebrate Champions of Science PR Newswire
Jan-09-19 05:45PM  Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know Zacks
01:29PM  JP Morgan's Dimon hosted a private dinner for pharma executives, and a major topic was Amazon CNBC
11:36AM  Why Johnson & Johnson Stock Fell 12% in December Motley Fool
09:45AM  Karyopharm Files MAA for Myeloma Candidate Selinexor in EU Zacks
08:48AM  The Zacks Analyst Blog Highlights: Visa, Coca-Cola, AbbVie, Johnson & Johnson and Duke Energy Zacks
08:25AM  Does Eli Lilly's $8 Billion Splurge Make Array BioPharma a Buy Now? Motley Fool
07:00AM  Innovation Puts Medtronic in the Lead Morningstar
05:00AM  Why Johnson & Johnson May Not Have to Pay Its $4.7 Billion Court Verdict Bloomberg
Jan-08-19 04:58PM  Here's What Caused Tandem Diabetes Stock to Gain a Jaw-Dropping 1,509% in 2018 Motley Fool
02:27PM  Top Analyst Reports for Visa, Coca-Cola & AbbVie Zacks
12:08PM  Latest trial in J&J talc litigations gets under way in California Reuters
11:34AM  Albany region cities sue pharmaceutical companies over opioid epidemic American City Business Journals
Jan-07-19 09:38PM  Latest trial in J&J talc litigations gets under way in California Reuters
09:30PM  Latest trial in Johnson & Johnson talc litigations gets under way in California Reuters
09:26PM  Latest trial in J&J talc litigations gets under way in California Reuters
03:46PM  8 Stocks To Outperform In An Uncertain Market Investopedia
02:24PM  Jon Najarian Sees Big Options Activity In Johnson & Johnson, Nvidia Benzinga
01:06PM  Options traders jump into J&J and this big tech name CNBC Videos
12:04PM  Johnson & Johnson Might Take a While to Recover With No Bottom in Sight
07:02AM  5 Things to Watch for at the JPMorgan Healthcare Conference Investopedia
Jan-06-19 12:00PM  Stock Market Power Rankings: Apple Cracks Motley Fool
09:06AM  Barron's Picks And Pans: Apple, Exxon, Morgan Stanley And More Benzinga
Jan-04-19 10:50PM  JOHNSON & JOHNSON INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Johnson & Johnson - JNJ Business Wire
06:09PM  AbbVie (ABBV) Inks Immunotherapy Deal with Private Biotech Zacks
04:24PM  Bristol To Become Top 5 Pharma And Other Fallout From Celgene Takeover Investor's Business Daily
07:29AM  Pfizer Begins Pivotal Study on Alopecia Areata Candidate Zacks
06:50AM  Today's Research Reports on Trending Tickers: Johnson & Johnson and Merck & Co. ACCESSWIRE
Jan-03-19 05:45PM  Johnson & Johnson (JNJ) Stock Moves -1.59%: What You Should Know Zacks
03:29PM  VIVUS (VVUS) Banks on New Drug Pancreaze, Qsymia Lacks Luster Zacks
01:24PM  Why Johnson & Johnson Stock is Clearly Set to Rise Again InvestorPlace
12:22PM  Triangle pharma inks deal with Johnson and Johnson that's potentially worth $818M American City Business Journals
11:11AM  Buy Apple Stock Once It Hits This Level InvestorPlace
09:54AM  Can the nose point the way to early lung cancer detection? This Peninsula company's Big Pharma deal aims to find out American City Business Journals
07:45AM  Stocks making the biggest moves premarket: AAPL, CELG, JNJ, UBS & more CNBC
07:17AM  Dow set to sink | Apple plunges 9% | Celgene surges on buyout offer CNBC
03:23AM  U.S. drugmaker J&J's India sales dip 3 percent in 2017/18: filing Reuters
01:55AM  U.S. drugmaker Johnson & Johnson's India sales dip 3 percent in 2017/18 - filing Reuters
Jan-02-19 04:05PM  Should You Reinvest Dividends? Motley Fool
02:39PM  [$$] Angel Medical Files for Bankruptcy The Wall Street Journal
09:25AM  Portola Up as Large-Scale Andexxa Production Gets FDA Nod Zacks
08:55AM  Johnson & Johnson Announces Quarterly Dividend for First Quarter 2019 PR Newswire
Dec-31-18 05:16PM  After damaging Reuters report, J&J doubles down on talc safety message Reuters
Dec-30-18 12:00PM  Stock Market Power Rankings: Dreaming of an Amazon Christmas Motley Fool
Dec-28-18 04:41PM  ATTENTION JNJ EMPLOYEES: Zamansky LLC Investigates Possible ERISA Violations in the Johnson & Johnson Retirement Savings Plan Business Wire
01:59PM  4 Top Stock Trades for Monday: GE, TSLA, Gold, JNJ InvestorPlace
01:34PM  19 Best Stocks to Buy for 2019 (And 5 to Sell) Kiplinger
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. Its Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, RoC, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads under the STAYFREE and CAREFREE brands, and tampons under the o.b. brand; wound care products comprising adhesive bandages under the BAND-AID brand and first aid products under the NEOSPORIN brand. The company's Pharmaceutical segment offers various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, cardiovascular and metabolic, and pulmonary hypertension diseases. Its Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; diabetes care products that include blood glucose monitoring; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PRINCE CHARLESDirectorDec 14Buy134.372,000268,73128,520Dec 17 08:37 AM
MULCAHY ANNE MDirectorDec 14Buy133.76748100,0506,537Dec 17 08:37 AM
PEREZ WILLIAM DDirectorDec 14Buy133.911,000133,9109,122Dec 17 08:37 AM
Kapusta Ronald AController, CAODec 13Sale147.313,643536,63813,641Dec 14 04:33 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Option Exercise96.7341,5634,020,237119,890Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Sale146.6841,5636,096,55278,327Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Option Exercise94.12125,13211,777,919203,459Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Sale146.32125,13218,308,68978,327Dec 06 05:27 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Option Exercise58.3330,9431,804,90570,817Nov 27 06:56 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Sale142.4630,9434,407,98539,874Nov 27 06:56 PM
Gorsky AlexChairman, CEONov 16Option Exercise62.39264,46516,500,026601,024Nov 16 07:44 PM
Gorsky AlexChairman, CEONov 16Sale145.96264,46538,600,968336,559Nov 16 07:44 PM
Kapusta Ronald AController, CAONov 08Sale145.158,4411,225,20017,284Nov 09 05:22 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Option Exercise62.9440,0002,517,526133,555Nov 09 05:20 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Sale144.3640,0005,774,48093,555Nov 09 05:20 PM
Kapusta Ronald AController, CAOSep 07Sale137.187,8991,083,60725,725Sep 11 03:53 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Option Exercise58.3329,0001,691,57059,124Aug 28 04:03 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Sale134.8029,0003,909,08430,124Aug 28 04:03 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Option Exercise90.44155,34214,049,130357,906Feb 20 07:46 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Sale129.86155,34220,172,401202,564Feb 20 07:46 PM
Caruso Dominic JExec VP, Finance; CFOFeb 09Option Exercise0.0010,6010154,703Feb 13 06:54 PM
Duato JoaquinExec VP, WW Chair, PharmaFeb 09Option Exercise0.009,812078,348Feb 13 06:54 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 09Option Exercise0.005,830069,992Feb 13 06:54 PM
Gorsky AlexChairman, CEOFeb 09Option Exercise0.0033,1650285,990Feb 13 06:54 PM
PETERSON SANDRA EExec VP, Group WW ChairmanFeb 09Option Exercise0.0011,445070,205Feb 13 06:54 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 09Option Exercise0.0013,2520181,655Feb 13 06:55 PM
Ullmann Michael HExec VP, General CounselFeb 09Option Exercise0.005,9530115,257Feb 13 06:55 PM
Kapusta Ronald AController, CAOFeb 09Option Exercise0.002,702032,666Feb 13 06:55 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 02Option Exercise0.0032,688032,688Feb 06 04:21 PM